Heart Test Laboratories Stock Today

Heart Test is selling for under 0.1 as of the 18th of February 2026; that is No Change since the beginning of the trading day. The stock's lowest day price was 0.1. The performance scores are derived for the period starting the 20th of November 2025 and ending today, the 18th of February 2026. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
15th of June 2022
Classification
Health Care
Valuation Profit Patterns
Check how we calculate scores

Heart Stock Highlights

President CEOAndrew Simpson
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.00110.0012
Notably Down
Slightly volatile
Total Current Liabilities2.4 M4.3 M
Way Down
Slightly volatile
Non Current Liabilities Total268.9 K283.1 K
Notably Down
Pretty Stable
Total Assets4.2 M4.9 M
Fairly Down
Slightly volatile
Total Current Assets3.2 M2.5 M
Significantly Up
Slightly volatile
Debt Levels
By employing borrowed capital, Heart Test can potentially magnify investment returns. Examining the debt-to-assets ratio offers investors perspective on Heart Test's use of financial leverage and reveals what portion of Heart Test's asset base relies on creditor financing.
Liquidity
Heart Test Laboratories has accumulated 2.99 M in total debt. Heart Test Laboratories has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Heart Test's use of debt, we should always consider it together with its cash and equity.

Depreciation

154,507
Heart Test Laboratories (HSCSW) is traded on NASDAQ Exchange in USA and employs 15 people. Heart Test is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company classifies itself under Health Care Equipment & Supplies sector and is part of Health Care industry. Heart Test Laboratories has accumulated about 723.48 K in cash with (7.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Heart Test Probability Of Bankruptcy

Heart Test Historical Income Statement

At this time, Heart Test's Depreciation And Amortization is fairly stable compared to the past year. Reconciled Depreciation is likely to climb to about 154.5 K in 2026, despite the fact that Net Interest Income is likely to grow to (427.9 K). View More Fundamentals

Heart Stock Against Markets

Heart Test Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Heart Test stock to make a market-neutral strategy. Peer analysis of Heart Test could also be used in its relative valuation, which is a method of valuing Heart Test by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Heart Test Corporate Executives

Elected by the shareholders, the Heart Test's board of directors comprises two types of representatives: Heart Test inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Heart. The board's role is to monitor Heart Test's management team and ensure that shareholders' interests are well served. Heart Test's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Heart Test's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mark HilzSecretary COOProfile

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.